Affiliated Zhongshan Hospital of Dalian University
Dalian, Liaoning, 116000, China
NCT Number: NCT03872362
The investigators aim to investigate the utility of radiomics to differentiate malignant nodules from benign nodules and invasive adenocarcinoma from non-invasive adenocarcinoma.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Dalian, Liaoning, 116000, China
With the development of computed tomography (CT) equipment and the increasing use of lung cancer screening programs with low-dose CT, a growing number of early-stage lung cancers were detected so that a large number of patients have undergone surgery.
Although a number of radiological studies have been used morphological signs so-called semantic features to make a differential diagnosis, it is still hard to apply by clinician because pulmonary nodules especially ground-glass nodules and small size nodules have atypical radiology signs and have strong subjectivity from different observers. Recently, CT-based radiomics, extracting the quantitative high-throughput features from medical images and facilitating clinical decision-making system, showed a good performance to predict diagnosis and prognosis of diverse cancer.
Therefore, the proposed project aims to develop and validate radiomics models based on CT images to identify malignant nodules and then to discriminate the different types of lung adenocarcinoma in patients with pulmonary nodules.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The high-throughput extraction of large amounts of quantitative image features from medical images
Time frame: 30 days
Model based on Radiomic that can differentiate malignant nodules from benign nodules.
Time frame: 30 days
Model based on Radiomic that can differentiate invasive adenocarcinoma from non-invasive adenocarcinoma.
Maastricht University
Other
Radiomics and Clinical Variables Can Differentiate Malignant Nodules and Detect Invasive Adenocarcinoma in Pulmonary Nodules: a Multi-center Study
Acronym: RMBPN
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02897778
Breast Diseases, Breast Neoplasms
San Antonio, Texas, United States
View Trial DetailsNCT02909452
Breast Diseases, Bronchial Diseases
San Antonio, Texas, United States
View Trial DetailsNCT06494241
Bronchial Diseases, Bronchial Neoplasms
Anning, China
View Trial DetailsNCT06376084
Bronchial Diseases, Bronchial Neoplasms
Shanghai, China
View Trial Details